650 related articles for article (PubMed ID: 33436433)
21. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
McCaughey G; McKevitt M; Elborn JS; Tunney MM
J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
[TBL] [Abstract][Full Text] [Related]
22. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
[TBL] [Abstract][Full Text] [Related]
23. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA
J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
[TBL] [Abstract][Full Text] [Related]
24. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
[No Abstract] [Full Text] [Related]
25. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
Konai MM; Haldar J
ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
[TBL] [Abstract][Full Text] [Related]
26. Antibiotics Enhance Prevention and Eradication Efficacy of Cathodic-Voltage-Controlled Electrical Stimulation against Titanium-Associated Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms.
Canty MK; Hansen LA; Tobias M; Spencer S; Henry T; Luke-Marshall NR; Campagnari AA; Ehrensberger MT
mSphere; 2019 May; 4(3):. PubMed ID: 31043516
[TBL] [Abstract][Full Text] [Related]
27. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
Field TR; White A; Elborn JS; Tunney MM
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
[TBL] [Abstract][Full Text] [Related]
28. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies.
Pang Z; Raudonis R; Glick BR; Lin TJ; Cheng Z
Biotechnol Adv; 2019; 37(1):177-192. PubMed ID: 30500353
[TBL] [Abstract][Full Text] [Related]
30. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
31. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
[TBL] [Abstract][Full Text] [Related]
32. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial Peptide-Loaded Nanoparticles as Inhalation Therapy for
Falciani C; Zevolini F; Brunetti J; Riolo G; Gracia R; Marradi M; Loinaz I; Ziemann C; Cossío U; Llop J; Bracci L; Pini A
Int J Nanomedicine; 2020; 15():1117-1128. PubMed ID: 32110011
[TBL] [Abstract][Full Text] [Related]
34. In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa.
Pawar V; Komor U; Kasnitz N; Bielecki P; Pils MC; Gocht B; Moter A; Rohde M; Weiss S; Häussler S
Antimicrob Agents Chemother; 2015 Aug; 59(8):4974-81. PubMed ID: 26055372
[TBL] [Abstract][Full Text] [Related]
35. Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.
Puckett SE; Reese KA; Mitev GM; Mullen V; Johnson RC; Pomraning KR; Mellbye BL; Tilley LD; Iversen PL; Freitag M; Geller BL
Antimicrob Agents Chemother; 2012 Dec; 56(12):6147-53. PubMed ID: 22985881
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
[TBL] [Abstract][Full Text] [Related]
38. Blocking RpoN reduces virulence of Pseudomonas aeruginosa isolated from cystic fibrosis patients and increases antibiotic sensitivity in a laboratory strain.
Lloyd MG; Vossler JL; Nomura CT; Moffat JF
Sci Rep; 2019 Apr; 9(1):6677. PubMed ID: 31040330
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial peptide Reg4 ameliorates
Wan X; Wang W; Zhu J; Xiao Y
Microbiol Spectr; 2024 May; 12(5):e0390523. PubMed ID: 38501823
[No Abstract] [Full Text] [Related]
40. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]